No Subject Date 32 Wellmarker Bio Shares its Plans on Clinical Trial with the Korean Economic Daily 2021-03-05 31 WellmarkerBio receives approval for Phase I clinical trial from the Australian Therapeutic Goods Administration 2021-03-03 30 Wellmarker Bio Introduces Medidata’s Solution to Clinical Study 2021-01-26 29 Wellmarker Bio Announces Phase I Clinical Trial Plan at the Korea Bio Investment Conference 2020 2020-12-28 28 Wellmarker Bio, an Outstanding Start-up to Watch in Korea 2020-12-24 27 Wellmarker Bio Attends ‘2020 BIO HEALTH FESTIVAL’ as an Innovative Start-up 2020-12-24 26 Wellmarker Bio Featured as an Innovative Growth Company at the Interview with The Korea Economic Daily 2020-11-30 25 Wellmarker Bio Wins Grand Prize for Two Consecutive Years 2020-10-20 24 Wellmarker Bio, Presents its Novel Colon Cancer Drug CTC Analysis Data at ASCO 2020 2020-06-02 23 Wellmarker Bio and AZothBio Signs Research Collaboration Agreement on Developing New Targeted Anticancer-drug 2020-04-07 1 2 3 4
